Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT)

Individualized targeted treatment in a case of a rare TFG::ROS1 fusion positive inflammatory myofibroblastic tumor (IMT)

Abstract Background Inflammatory myofibroblastic tumor (IMTs) are rare mesenchymal neoplasms with slow growth. Resection is considered as therapeutic standard, with chemotherapy being insufficiently effective in advanced disease. ALK translocations are present in 50% of cases, ROS1 fusions (YWHAE::R...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs: Sebastian Sommer, Maximilian Schmutz, Tina Schaller, Patrick Mayr, Sebastian Dintner, Bruno Märkl, Ralf Huss, M. Monika Golas, Michaela Kuhlen, Frank Jordan, Rainer Claus, Bernhard Heinrich
Formaat: Artikel
Taal:English
Gepubliceerd in: Wiley 2024-01-01
Reeks:Cancer Reports
Onderwerpen:
crizotinib
inflammatory myofibrolastic tumor (IMT)
personalized oncology
ROS1 fusion
targeted therapy
TKI
Online toegang:https://doi.org/10.1002/cnr2.1916

Internet

https://doi.org/10.1002/cnr2.1916

Gelijkaardige items